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Apoptosis has been shown to serve as a 
mechanism by which cells infected with 
viruses, bacteria, or intracellular parasites 
can be eliminated without eliciting an 
unwanted inflammatory response. Not 
surprisingly intracellular pathogens have 
evolved mechanisms by which to inhibit 
apoptosis, not only avoiding the elimina-
tion of the host cell but also extending its life 
span. Inhibition of apoptosis by intracellu-
lar pathogens is accomplished by affecting 
the fine balance between pro- and anti-
apoptotic factors in the infected cell. One 
mechanism utilized by various microbes is 
regulation of the pro- and anti-apoptotic 
proteins of the BCL-2 family (Carmen and 
Sinai, 2007; Faherty and Maurelli, 2008; 
Galluzzi et al., 2008). The BCL-2 family 
includes the pro-apoptotic proteins BCL-2-
associated X protein (BAX) and the BCL-2 
antagonist/killer-1 (BAK), which directly 
participate in the release of Cytochrome 
C from mitochondria (Youle and Strasser, 
2008). Other members of the BCL-2 fam-
ily (e.g., BAD, BID, BIM) participate in 
the direct or indirect activation of BAX or 
BAK, thus having pro-apoptotic effects, 
while others (e.g., BCL-2 and BCL-XL) 
inhibit these pore forming proteins, thus 
acting as anti-apoptotic agents (Youle and 
Strasser, 2008).
In a recent Frontiers in Cellular and 
Infection Microbiology research arti-
cle, Carmen and Sinai (2011) show that 
Toxoplasma gondii, an important patho-
genic parasite of humans and other ani-
mals, affects the stability of several BCL-2 
family proteins via a diversity of proteolytic 
activities. In order to ensure its survival and 
successful propagation within an infected 
host, T. gondii inhibits apoptosis in infected 
cells. Anti-apoptotic events associated with 
T. gondii infection include activation of 
the nuclear factor-κ B (NF-κB) inhibition 
of phosphoinositide 3-kinase (PI3-K), 
Cytochrome C release from the mitochon-
drion, and direct inhibition of the apop-
tosome activity (reviewed in Carmen and 
Sinai, 2007; Laliberte and Carruthers, 2008). 
Obstruction of Cytochrome C release in T. 
gondii infected cells has been reported to 
correlate with increase of BCL-2 transcript 
level inhibition of mitochondrial targeting 
and activation of BAX (Hippe et al., 2009), 
as well as selective degradation of the pro-
apoptotic proteins BAX, BAD, and BID 
(Goebel et al., 2001; Molestina et al., 2003). 
Degradation of pro-apoptotic members of 
the BCL-2 family is also observed with other 
pathogens such as Chlamydia trachomatis 
(Dong et al., 2005).
To better define the requirements for the 
T. gondii dependent degradation of BCL-2 
family proteins, Carmen and Sinai (2011) 
have now analyzed the levels of BCL-2 
family proteins at varying multiplicities 
of infection (MOI) and in the presence of 
inhibitors for distinct classes of proteases. 
While these experiments intrinsically 
exhibit a great degree of variability, ratio-
metric analysis combined with rigorous sta-
tistical analysis has allowed the authors to 
uncover trends that reveal the complexity of 
the effect of T. gondii infection on the stabil-
ity of BCL-2 family members. Their analysis 
was focused on anti-apoptotic BCL-2, and 
the pro-apoptotic proteins BAX, BAD, and 
BID. While the transcript level of BCL-2 
increases upon infection (Molestina et al., 
2003), there is no difference in the levels 
of BCL-2 protein between uninfected and 
heavily infected cells. Thus, it is plausible 
that T. gondii is overcoming an increase 
in BCL-2 turnover in response to infec-
tion by up-regulating its transcription. By 
contrast, while T. gondii infection increases 
transcript levels of pro-apoptotic genes 
BAD and BID (Molestina et al., 2003), their 
protein products are reduced at high MOIs. 
Parasite dependent protein degradation is 
also observed for BAX. By also performing 
these experiments in mutant human cells, 
the authors find that none of the effects on 
the stability of BCL-2 proteins is depend-
ent NF-κB. This suggests that T. gondii can 
regulate the life span of the host cell by both 
NF-κB dependent and independent mecha-
nism to block apoptosis.
By analyzing stability trends with 
increasing MOIs in the presence of spe-
cific inhibitors it was determined that the 
T. gondii dependent degradation of BAD 
and BID depends on the activity of the 
proteasome. This suggests a role for ubiq-
uitination in the parasite dependent turn 
over of these proteins. The degradation of 
these two pro-apoptotic factors upon para-
site infection was also disrupted by addi-
tion of inhibitors of either trypsin-like or 
chymotrypsin-like proteases, but was not 
affected by a cysteine protease inhibitor. 
On the other hand the parasite depend-
ent degradation of BAX was resistant to all 
inhibitors tested indicating that a type of 
proteolytic activity different from cysteine, 
trypsin-like, or chymotrypsin-like protease 
is responsible for its infection-dependent 
turnover. Intriguingly, in the presence of 
cysteine protease inhibitor, BAX actually 
became more sensitive to parasite depend-
ent degradation. This suggests that BAX is 
partly protected from parasite dependent 
degradation by the action of a cysteine pro-
tease. An interesting aspect of this study is 
that by looking at the effect of the inhibi-
tors in uninfected cells the authors can draw 
some conclusions about how normal levels 
of BCL-2 family members are maintained. 
Thus, it appears that steady state levels of 
BAD and BAX are maintained by cysteine 
protease driven turnover, while the steady 
state level of BID is regulated by trypsin-like 
proteolytic activity.
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An important question that remains 
unresolved is whether the T. gondii depend-
ent turnover of the anti-apoptotic mem-
bers of the BCL-2 family is due to parasite 
or host derived proteins. Evidence that 
parasite proteins are delivered into the 
host cell (Laliberte and Carruthers, 2008) 
opens the possibility that T. gondii secretes 
proteins that directly target host factors 
for selective degradation. Nonetheless, it 
is most likely that a parasite protein medi-
ates activation of intrinsic cellular path-
ways for degradation. Regardless, a better 
understanding of how T. gondii infection 
leads to the degradation of these important 
regulators of apoptosis is likely to provide 
new insights into the normal dynamics of 
BCL-2 family proteins.
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